Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATP1A1 | P05023 | 7/20 | 0.72 |
| ▸ | ATP1B1 | P05026 | 7/20 | 0.72 |
| ▸ | ATP1A3 | P13637 | 7/20 | 0.72 |
| ▸ | ATP1B2 | P14415 | 7/20 | 0.72 |
| ▸ | ATP1A2 | P50993 | 7/20 | 0.72 |
| ▸ | ATP1B3 | P54709 | 7/20 | 0.72 |
| ▸ | FXYD2 | P54710 | 7/20 | 0.72 |
| ▸ | ATP1A4 | Q13733 | 7/20 | 0.72 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.72 |
| ▸ | CYP3A5 | P20815 | 2/20 | 0.72 |
| ▸ | AR | P10275 | 1/20 | 0.72 |
| ▸ | ZFP91 | Q96JP5 | 1/20 | 0.72 |
| ▸ | CYP3A7 | P24462 | 1/20 | 0.52 |
| ▸ | STAT3 | P40763 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | PAX8 | Q06710 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bufogenin SCHEMBL309406 | 1.00 | ATP1A1 (0.72) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| Bufogenin SCHEMBL16628192 | 1.00 | ATP1A1 (0.72) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| Bufogenin SCHEMBL1652389 | 1.00 | ATP1A1 (0.72) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| Bufogenin SCHEMBL4528502 | 1.00 | ATP1A1 (0.72) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| Bufogenin SCHEMBL8168075 | 1.00 | ATP1A1 (0.72) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| Bufogenin SCHEMBL21840080 | 0.99 | ATP1A1 (0.70) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| Bufogenin SCHEMBL9098303 | 0.98 | ATP1A1 (0.69) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| Bufogenin SCHEMBL10587453 | 0.97 | ATP1A1 (0.68) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| Bufogenin SCHEMBL9752159 | 0.97 | ATP1A1 (0.68) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| Bufogenin SCHEMBL17652299 | 0.97 | ATP1A1 (0.68) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 8924 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122075504-A | Application of bufogenin medicament in preparation of IHNV (infectious bursal disease virus) resisting product | — | 2026-05-26 | — | — | CN | claimed |
| WO-2026102542-A1 | ATPASE INHIBITORS FOR TREATMENT OF NEUROLOGICAL AND NON-NEUROLOGICAL DISORDERS | HAPLO THERAPEUTICS INC. (CA) | 2026-05-21 | — | — | WO | claimed |
| CN-122005549-A | Application of indole alkali compound in preparation of medicine or skin care product for treating or preventing skin diseases | 南京效真生物科技有限公司 | 2026-05-12 | — | — | CN | claimed |
| EP-4363043-B1 | COMPOSITIONS FOR USE IN METHODS FOR INCREASING CANCER CELL SENSITIVITY TO ALTERNATING ELECTRIC FIELDS | NOVOCURE GMBH (CH) | 2026-04-22 | — | — | EP | claimed |
| US-12594421-B2 | Compositions and methods for increasing cancer cell sensitivity to alternating electric fields | NOVOCURE GMBH (CH) | 2026-04-07 | — | — | US | claimed |
| US-20250339680-A1 | COMPOSITIONS AND METHODS FOR INCREASING CANCER CELL SENSITIVITY TO ALTERNATING ELECTRIC FIELDS | NOVOCURE GMBH (CH) | 2025-11-06 | — | — | US | claimed |
| EP-4615506-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | Sahin, Fikret (TR) | 2025-09-17 | — | — | EP | claimed |
| WO-2025120106-A1 | METHODS FOR ISOLATING EMBRYONIC STEM CELLS FROM AN AVIAN EMBRYO CELLS | SUPRÊME (FR) | 2025-06-12 | — | — | WO | claimed |
| EP-4567102-A1 | METHODS FOR ISOLATING EMBRYONIC STEM CELLS FROM AVIAN EMBRYONIC CELLS | Suprême (FR) | 2025-06-11 | — | — | EP | claimed |
| CN-120077031-A | Prodrug kit for multitube concurrent chemotherapy | 亚历克斯·祖内克 | 2025-05-30 | — | — | CN | claimed |
| EP-0016036-A4 | ORGANOSILICON INFILTRATED REACTION SINTERED SILICON NITRIDE. | US HEALTH (US) | 1980-09-29 | — | — | EP | claimed |
| WO-1980001664-A1 | METHOD AND DEVICE FOR GENTLE TREATMENT OF SPHERICAL BALLS | PROJECTUS IND PRODUKTER AB | 1980-08-21 | — | — | WO | claimed |
| EP-0012762-A1 | SIGNAL TRANSLATOR WITH SQUELCH. | BEI ELECTRONICS (US) | 1980-07-09 | — | — | EP | claimed |
| WO-1980000740-A1 | PIPE COUPLING DEVICE | NOLEK SYSTEM AB | 1980-04-17 | — | — | WO | claimed |
| EP-0009032-A1 | Carrier having two wheels inclined towards one another. | TODER ELLIS I | 1980-03-19 | — | — | EP | claimed |
| WO-1980000021-A1 | ORGANOSILICON INFILTRATED REACTION SINTERED SILICON NITRIDE | US COMMERCE (US) | 1980-01-10 | — | — | WO | claimed |
| WO-1979001062-A1 | COMBINED COAL LIQUEFACTION AND GASIFICATION PROCESS | GULF OIL CORP (US) | 1979-12-13 | — | — | WO | claimed |
| WO-1979000906-A1 | RECOVERY OF ELEMENTAL SULFUR AND METAL VALUES FROM TAILINGS FROM COPPER RECOVERY PROCESSES | CYPRUS METALLURG PROCESS (US) | 1979-11-15 | — | — | WO | claimed |
| WO-1979000728-A1 | SIGNAL TRANSLATOR WITH SQUELCH | BEI ELECTRONICS (US) | 1979-10-04 | — | — | WO | claimed |
| WO-1979000662-A1 | CANTED WHEELS CARRIER | TODER E | 1979-09-06 | — | — | WO | claimed |